FDA Drug Recalls

Recalls / Class II

Class IID-0486-2023

Product

Simvastatin, USP, 40 mg, Rx Only, Packaged as a 90-count bottle, NDC 61919-0431-90, Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534

Affected lot / code info
Lot, expiry: 28AP2212 , exp 7/31/2024 ; 24MA2230, exp 7/31/2024; 11JA2203 , exp 3/31/2023; 02FE2217 , exp 2/28/2023; 10DE2126 , exp 2/28/2023; 25MA2201, exp 5/31/2023; 28FE2230, exp 5/31/2023.

Why it was recalled

cGMP deviations

Recalling firm

Firm
Direct Rx
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
94 Worldwide Dr, N/A, Dawsonville, Georgia 30534-6828

Distribution

Quantity
269 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2023-03-13
FDA classified
2023-03-24
Posted by FDA
2023-04-05
Terminated
2024-06-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0486-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.